Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus

Clinical Rheumatology

Volumn 32, Issue 12, 2013, Pages 1727-1734

  Su, Gaixiu ^a,c   Luan, Zuo ^b   Wu, Fengqi ^a   Wang, Xinning ^a   Tang, Xiangfeng ^b   Wu, Nanhai ^b   Wang, Kai ^b  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

^b NAVY GENERAL HOSPITAL   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Autologous; Follow up; Paediatric; SLE; Stem cell; Transplantation

Indexed keywords

AUTOANTIBODY; CARMUSTINE; CD19 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; GANCICLOVIR; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELPHALAN; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SULFAMETOXYDIAZINE; THYMOCYTE ANTIBODY;

ADOLESCENT; ANAPHYLACTIC SHOCK; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTHRITIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN DISEASE; CD3+ T LYMPHOCYTE; CD34 SELECTION; CD4 CD8 RATIO; CHILD; CHINESE MEDICINE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DISEASE SEVERITY; ERYTHROCYTE; FACE ERYTHEMA; FEMALE; FEVER; FOLLOW UP; HEART INJURY; HUMAN; INFECTION PREVENTION; INFLAMMATION; INTERSTITIAL PNEUMONIA; LEUKOCYTE; LIVER INJURY; MACROPHAGE ACTIVATION SYNDROME; MALE; MUSCLE ATROPHY; NEPHRITIS; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; QUALITY OF LIFE; RASH; RECURRENT DISEASE; REMISSION; SCHOOL CHILD; SLEDAI; STEM CELL MOBILIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; VIREMIA;

ADOLESCENT; ANTIGENS, CD19; ANTIGENS, CD34; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84890426974     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2324-1     Document Type: Article

References (25)

1. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED (2008) Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152(4):550-556
2. Stichweh D, Arce E, Pascual V (2004) Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 16(5):577-587
3. Tyndal A, Gratwohl A (1997) Blood and marrow stem cell transplantation in autoimmune disease: a consensus report written on behalf of the European League against Rheumatism and the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 19:643-645
4. Marmont AM (1998) Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 83(8):733-743
5. Traynor AE, Schroeder J, Rosa RM, Cheng D, Stefka J, Mujais S, Baker S, Burt RK (2000) Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 356(9231):701-707
6. Tyndall A (2001) Immunoablation and haemopoietic stem cell transplantation for severe autoimmune disease with special reference to systemic lupus erythematosus. Lupus 10(3):214-215
7. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR (2001) Systemic lupus erythematosus. Lancet 357(9261):1027-1032
8. Wulffraat NM, Sanders LA, Kuis W (2000) Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2(4):316-323
9. Wu FQ, Luan Z, Lai JM, Tang XF, Lu J, Liu ZW, Wang TY (2007) Treatment of refractory rheumatism among preschool children with autologous peripheral blood hematopoietic stem cell transplantation. Zhonghua Er Ke Za Zhi 45(11):809-813
10. Tyndall A (2012) Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases. Pediatr Res 71(4 Pt 2):433-438
11. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
12. Gladman DD, Ibañez D (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288-291
13. Weening JJ, D'Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521-530
14. Li H, Ji CY, Zong XN, Zhang YQ (2009) Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi 47(7):487-492
15. Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56(7):481-490
16. Sestak AL, Nath SK (2007) Current status of lupus genetics. Arthritis Res Ther 9(3):210
17. Petri M, Jones RJ, Bmdsky RA (2003) High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 48:166-173
18. Gladstone DE, Presturd AA, Pradhan A et al (2002) High-dose cyclophosphamide for severe systemic lupus erythematosus. Lupus 11:405-410
19. van Bekkum DW (2003) Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 32(Suppl 1):S37-S39
20. Pavletic SZ, Illei GG (2005) The role of immune ablation and stem cell transplantation in severe SLE. Best Pract Res Clin Rheumatol 19(5):839-858
21. Brunner HI, Gladman DD (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58(2):556-562
22. Papadimitraki ED, Isenberg DA (2009) Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 5:391-403
23. Weinberg K, Blazar BR, Wagner JE, Agura E, Hill BJ, Smogorzewska M, Koup RA, Betts MR, Collins RH, Douek DC (2001) Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97(5):1458-1466
24. Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, Martini A, Ravelli A (2007) Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 16(8):587-592
25. Sreedharan A, Bowyer S, Wallace CA, Robertson MJ, Schmidt K, Woolfrey AE, Nelson RP Jr (2006) Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant 37(7):629-634